Systemic corticosteroid and reactivation of chronic hepatitis B

Respirology

Volumn 15, Issue 7, 2010, Pages 1017-1018

  Lai, Ching Lung ^a   Yuen, Man Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

antiviral therapy; asthma; chronic obstructive pulmonary disease; hepatitis B reactivation; systemic corticosteroid

Indexed keywords

ALPHA INTERFERON; ANTIINFECTIVE AGENT; CORTICOSTEROID; ENTECAVIR; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; MEMBRANE ANTIGEN; PREDNISOLONE; TENOFOVIR;

AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ASTHMA; BLOOD EXAMINATION; CHRONIC HEPATITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; DISEASE CARRIER; DRUG WITHDRAWAL; EDITORIAL; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LYMPHOMA; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; SIDE EFFECT; SUPPRESSOR CELL; VIRUS LOAD; VIRUS REACTIVATION;

ADRENAL CORTEX HORMONES; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; RECURRENCE; VIRUS ACTIVATION;

EID: 77957270579     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01822.x     Document Type: Editorial

References (11)

1. Lai CL, Yuen MF. What is the best end point for hepatitis B treatment? Ann. Intern. Med. 2008 148 : 560. (Pubitemid 351665426)
2. Yuen MF, Yuan HJ, Hui CK et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 2003 53 : 416 19.
3. Wands JR, Chura CM, Roll FJ et al. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975 68 : 105 12.
4. Lau JY, Lai CL, Lin HJ et al. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q. J. Med. 1989 73 : 911 17.
5. Tur-Kaspa R, Burk RD, Shaul Y et al. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc. Natl. Acad. Sci. U.S.A. 1986 83 : 1627 31. (Pubitemid 16011137)
6. Hanson RG, Peters MG, Hoofnagle JH. Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis. Hepatology 1986 6 : 173 9.
7. Perrillo RP, Schiff ER, Davis GL et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N. Engl. J. Med. 1990 323 : 295 301.
8. Onwubalili JK. Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy. Postgrad. Med. J. 1988 64 : 325 7.
9. Koga Y, Kumashiro R, Yasumoto K et al. Two fatal cases of hepatitis B virus carriers after corticosteroid therapy for bronchial asthma. Intern. Med. 1992 31 : 208 13.
10. Kim TW, Kim MN, Kwon JW et al. Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids. Respirology 15 : 1092 7.
11. Lai CL, Yuen MF. Chronic hepatitis B - new goals, new treatment. N. Engl. J. Med. 2008 359 : 2488 91.